Variant report
Variant | nsv528542 |
---|---|
Chromosome Location | chr9:26509378-26515052 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs548508453 | chr9:26510857-26510858 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs566811815 | chr9:26510867-26510868 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527565891 | chr9:26510869-26510870 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs185170729 | chr9:26510879-26510880 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs570595617 | chr9:26510915-26510916 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs189930168 | chr9:26510949-26510950 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs570201562 | chr9:26510961-26510962 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs17753877 | chr9:26511000-26511001 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs552910802 | chr9:26511235-26511236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs557594301 | chr9:26511276-26511277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12336208 | chr9:26511294-26511295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs527610400 | chr9:26511316-26511317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552411652 | chr9:26511341-26511342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147865683 | chr9:26511346-26511347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192062131 | chr9:26511347-26511348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549561118 | chr9:26511357-26511358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568254022 | chr9:26511362-26511363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558829462 | chr9:26511379-26511380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535541005 | chr9:26511385-26511386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs183778893 | chr9:26511391-26511392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs377010197 | chr9:26511413-26511414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544177807 | chr9:26511467-26511468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs35414024 | chr9:26511468-26511469 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs558391367 | chr9:26511506-26511507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs114418689 | chr9:26511529-26511530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs140453346 | chr9:26511570-26511571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555979725 | chr9:26511588-26511589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34876072 | chr9:26511604-26511605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs574611583 | chr9:26511674-26511675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs138080562 | chr9:26511679-26511680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370525059 | chr9:26511683-26511684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs71508677 | chr9:26511749-26511750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs541915704 | chr9:26511750-26511751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559905359 | chr9:26511767-26511768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs111711229 | chr9:26511774-26511775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs188020464 | chr9:26511807-26511808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs572394858 | chr9:26511814-26511815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192564336 | chr9:26511815-26511816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs113371414 | chr9:26511819-26511820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs7867285 | chr9:26511835-26511836 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs145423110 | chr9:26511839-26511840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs149187582 | chr9:26511846-26511847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs62544373 | chr9:26511876-26511877 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs145130531 | chr9:26511910-26511911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs547452036 | chr9:26511932-26511933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs565952516 | chr9:26511971-26511972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs17753889 | chr9:26512020-26512021 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs551484360 | chr9:26512051-26512052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs570370751 | chr9:26512058-26512059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs537717413 | chr9:26512105-26512106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21858162 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
polycythaemia | 22829968 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21364760 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:26510800-26511000 | Bivalent Enhancer | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr9:26511200-26511400 | Enhancers | Fetal Kidney | kidney |
3 | chr9:26511400-26512400 | Weak transcription | Fetal Kidney | kidney |
4 | chr9:26512400-26512600 | Enhancers | Fetal Kidney | kidney |